news bytes
fumarate dehydrate delivered
through a special device. It is
indicated for
treatment of
severe Asthma
and for
patients with
moderate to
severe COPD
with frequent
symptoms and
a history of exacerbations.
Symbicort is approved for use in
91 countries for the treatment
of Asthma and COPD. Results
from AstraZeneca’s two major
clinical studies have shown that
the addition of formoterol to
budesonide improved asthma
symptoms and lung function, and
reduced exacerbation.
SUN PHARMA PARTNERS WITH
NIV TO TEST PHYTOPHARMA
DRUGS FOR ZIKA, CHIKUNGUNYA
& DENGUE
Sun Pharmaceutical Industries
and the National Institute of
Virology (NIV), Pune recently
signed an agreement for testing
phytopharmaceutical, biologic and
chemical entities developed by Sun
Pharma against Zika, chikungunya
and dengue viruses. Sun Pharma
60
BioVoiceNews | July 2017
will
provide
drug
molecules
to NIV for
testing
against
Zika,
chikungunya and dengue viruses.
The phytopharmaceuticals are
being developed for treating
individuals infected with Zika
virus and possibly for curing Zika
disease.These phytopharmaceutical
candidates have been isolated from
plants found in India. In the case
of chikungunya, Sun Pharma has
identified certain chemical entities
in house which would be tested at
NIV. The drug molecules will be
tested against all the three viruses
through laboratory studies (in
vitro) and the promising candidates
will be tested on animals.
ICGEB CELEBRATES ITS
30 YEARS OF BIOSCIENCE
RESEARCH
This year, the International Centre
for Genetic Engineering and
Biotechnology (ICGEB) celebrates
thirty years of activity dedicated to
international advanced research
and training in the life sciences.